Filing Details

Accession Number:
0001209191-16-134640
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-01 17:04:51
Reporting Period:
2016-07-28
Filing Date:
2016-08-01
Accepted Time:
2016-08-01 17:04:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1232505 J Robert Hugin C/o Celgene Corporation
86 Morris Avenue
Summit NJ 07901
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-07-28 100,000 $110.00 1,022,201 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2016-08-01 29,669 $0.00 29,669 $114.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,669 2026-08-01 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 490 Indirect 401(k) Plan
Common Stock 9,600 Indirect Children
Footnotes
  1. These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan.
  2. Option is immediately exercisable and will vest in four equal annual installments commencing on August 1, 2017.
  3. The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of June 15, 2015).